Integer Holdings Corporation (ITGR)
USD 131.5
(-3.79%)
USD 131.5
(-3.79%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 90.65 Million USD | 36.57% |
| 2022 | 66.37 Million USD | -31.43% |
| 2021 | 96.8 Million USD | 25.3% |
| 2020 | 77.25 Million USD | -19.8% |
| 2019 | 96.33 Million USD | -42.64% |
| 2018 | 167.96 Million USD | 151.9% |
| 2017 | 66.67 Million USD | 1018.59% |
| 2016 | 5.96 Million USD | 178.5% |
| 2015 | -7.59 Million USD | -113.69% |
| 2014 | 55.45 Million USD | 52.92% |
| 2013 | 36.26 Million USD | 855.72% |
| 2012 | -4.79 Million USD | -114.49% |
| 2011 | 33.12 Million USD | -0.05% |
| 2010 | 33.13 Million USD | 468.16% |
| 2009 | -9 Million USD | -148.5% |
| 2008 | 18.55 Million USD | 23.32% |
| 2007 | 15.05 Million USD | -6.67% |
| 2006 | 16.12 Million USD | 59.55% |
| 2005 | 10.1 Million USD | -37.83% |
| 2004 | 16.25 Million USD | -30.19% |
| 2003 | 23.28 Million USD | 62.16% |
| 2002 | 14.36 Million USD | 67.05% |
| 2001 | 8.59 Million USD | 1668.8% |
| 2000 | -548 Thousand USD | 75.88% |
| 1999 | -2.27 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 20.5 Million USD | -22.19% |
| 2024 Q2 | 31.24 Million USD | 52.36% |
| 2024 Q3 | 35.43 Million USD | 13.42% |
| 2023 Q3 | 27.25 Million USD | 13.71% |
| 2023 FY | 90.65 Million USD | 36.57% |
| 2023 Q4 | 26.35 Million USD | -3.3% |
| 2023 Q1 | 13.06 Million USD | -27.89% |
| 2023 Q2 | 23.97 Million USD | 83.47% |
| 2022 Q1 | 11.36 Million USD | -52.22% |
| 2022 FY | 66.37 Million USD | -31.43% |
| 2022 Q4 | 18.11 Million USD | 12.83% |
| 2022 Q3 | 16.05 Million USD | -22.94% |
| 2022 Q2 | 20.83 Million USD | 83.3% |
| 2021 FY | 96.8 Million USD | 25.3% |
| 2021 Q3 | 22.06 Million USD | -25.03% |
| 2021 Q4 | 23.78 Million USD | 7.81% |
| 2021 Q1 | 21.52 Million USD | 39.5% |
| 2021 Q2 | 29.43 Million USD | 36.77% |
| 2020 Q4 | 15.42 Million USD | -49.16% |
| 2020 Q2 | 389 Thousand USD | -98.75% |
| 2020 Q1 | 31.1 Million USD | 182.11% |
| 2020 FY | 77.25 Million USD | -19.8% |
| 2020 Q3 | 30.34 Million USD | 7700.0% |
| 2019 Q1 | 21.66 Million USD | -15.83% |
| 2019 Q4 | 11.02 Million USD | -63.96% |
| 2019 Q2 | 33.05 Million USD | 52.55% |
| 2019 Q3 | 30.58 Million USD | -7.47% |
| 2019 FY | 96.33 Million USD | -42.64% |
| 2018 FY | 167.96 Million USD | 151.9% |
| 2018 Q4 | 25.74 Million USD | -77.43% |
| 2018 Q3 | 114.07 Million USD | 469.77% |
| 2018 Q2 | 20.02 Million USD | 146.64% |
| 2018 Q1 | 8.11 Million USD | -85.06% |
| 2017 Q2 | 2.99 Million USD | 168.91% |
| 2017 Q3 | 13.69 Million USD | 357.86% |
| 2017 Q4 | 54.33 Million USD | 296.92% |
| 2017 FY | 66.67 Million USD | 1018.59% |
| 2017 Q1 | -4.33 Million USD | -154.7% |
| 2016 FY | 5.96 Million USD | 178.5% |
| 2016 Q1 | -12.66 Million USD | 49.17% |
| 2016 Q2 | -770 Thousand USD | 93.92% |
| 2016 Q3 | 11.45 Million USD | 1588.05% |
| 2016 Q4 | 7.93 Million USD | -30.76% |
| 2015 Q3 | 22 Thousand USD | -99.76% |
| 2015 Q1 | 8 Million USD | -43.51% |
| 2015 Q4 | -24.9 Million USD | -113313.64% |
| 2015 FY | -7.59 Million USD | -113.69% |
| 2015 Q2 | 9.28 Million USD | 15.92% |
| 2014 Q3 | 14.01 Million USD | 13.48% |
| 2014 Q2 | 12.34 Million USD | -17.25% |
| 2014 Q1 | 14.92 Million USD | 52.56% |
| 2014 FY | 55.45 Million USD | 52.92% |
| 2014 Q4 | 14.17 Million USD | 1.17% |
| 2013 Q3 | 11.07 Million USD | 13.53% |
| 2013 FY | 36.26 Million USD | 855.72% |
| 2013 Q4 | 9.78 Million USD | -11.65% |
| 2013 Q2 | 9.75 Million USD | 72.21% |
| 2013 Q1 | 5.66 Million USD | 201.93% |
| 2012 Q3 | -7.56 Million USD | -296.34% |
| 2012 FY | -4.79 Million USD | -114.49% |
| 2012 Q2 | 3.85 Million USD | -13.79% |
| 2012 Q1 | 4.46 Million USD | -20.78% |
| 2012 Q4 | -5.55 Million USD | 26.52% |
| 2011 Q3 | 6.98 Million USD | -18.26% |
| 2011 FY | 33.12 Million USD | -0.05% |
| 2011 Q4 | 5.63 Million USD | -19.32% |
| 2011 Q2 | 8.55 Million USD | -28.42% |
| 2011 Q1 | 11.94 Million USD | -13.69% |
| 2010 FY | 33.13 Million USD | 468.16% |
| 2010 Q2 | 7.78 Million USD | 40.4% |
| 2010 Q1 | 5.54 Million USD | 461.6% |
| 2010 Q4 | 13.83 Million USD | 132.04% |
| 2010 Q3 | 5.96 Million USD | -23.42% |
| 2009 Q3 | -20.69 Million USD | -415.35% |
| 2009 FY | -9 Million USD | -148.5% |
| 2009 Q4 | -1.53 Million USD | 92.59% |
| 2009 Q2 | 6.56 Million USD | -1.53% |
| 2009 Q1 | 6.66 Million USD | -21.59% |
| 2008 Q4 | 8.49 Million USD | 11.4% |
| 2008 Q3 | 7.62 Million USD | 31.42% |
| 2008 Q2 | 5.8 Million USD | 272.05% |
| 2008 Q1 | -3.37 Million USD | -221.37% |
| 2008 FY | 18.55 Million USD | 23.32% |
| 2007 Q1 | 10.66 Million USD | 665.35% |
| 2007 Q2 | -3.39 Million USD | -131.86% |
| 2007 Q3 | 5 Million USD | 247.1% |
| 2007 Q4 | 2.78 Million USD | -44.4% |
| 2007 FY | 15.05 Million USD | -6.67% |
| 2006 FY | 16.12 Million USD | 59.55% |
| 2006 Q4 | 1.39 Million USD | -56.96% |
| 2006 Q3 | 3.23 Million USD | -33.12% |
| 2006 Q1 | 6.65 Million USD | 9679.41% |
| 2006 Q2 | 4.84 Million USD | -27.17% |
| 2005 FY | 10.1 Million USD | -37.83% |
| 2005 Q4 | 68 Thousand USD | -91.01% |
| 2005 Q3 | 756 Thousand USD | -85.68% |
| 2005 Q2 | 5.28 Million USD | 31.9% |
| 2005 Q1 | 4 Million USD | 115.33% |
| 2004 FY | 16.25 Million USD | -30.19% |
| 2004 Q3 | 3.04 Million USD | -35.64% |
| 2004 Q4 | 1.85 Million USD | -38.97% |
| 2004 Q2 | 4.73 Million USD | -28.49% |
| 2004 Q1 | 6.61 Million USD | 46.34% |
| 2003 Q1 | 6.03 Million USD | 21.74% |
| 2003 FY | 23.28 Million USD | 62.16% |
| 2003 Q4 | 4.52 Million USD | -41.83% |
| 2003 Q3 | 7.77 Million USD | 57.03% |
| 2003 Q2 | 4.95 Million USD | -17.97% |
| 2002 Q2 | 3.58 Million USD | 7.4% |
| 2002 Q1 | 3.33 Million USD | 23.16% |
| 2002 FY | 14.36 Million USD | 67.05% |
| 2002 Q4 | 4.95 Million USD | 100.2% |
| 2002 Q3 | 2.47 Million USD | -30.93% |
| 2001 Q1 | -75 Thousand USD | -106.89% |
| 2001 FY | 8.59 Million USD | 1668.8% |
| 2001 Q2 | 2.64 Million USD | 3632.0% |
| 2001 Q3 | 3.31 Million USD | 25.03% |
| 2001 Q4 | 2.71 Million USD | -18.15% |
| 2000 Q3 | -860 Thousand USD | 0.0% |
| 2000 Q4 | 1.08 Million USD | 226.51% |
| 2000 FY | -548 Thousand USD | 75.88% |
| 1999 FY | -2.27 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott Laboratories | 5.72 Billion USD | 98.416% |
| Allurion Technologies Inc. | -82.3 Million USD | 210.14% |
| Artivion, Inc. | -30.69 Million USD | 395.373% |
| Avanos Medical, Inc. | -61.8 Million USD | 246.683% |
| Butterfly Network, Inc. | -133.69 Million USD | 167.801% |
| Butterfly Network, Inc. | -133.69 Million USD | 167.801% |
| Bio-Rad Laboratories, Inc. | -637.32 Million USD | 114.224% |
| Boston Scientific Corporation | 1.59 Billion USD | 94.309% |
| Perspective Therapeutics, Inc. | -14.67 Million USD | 717.928% |
| CONMED Corporation | 64.45 Million USD | -40.632% |
| Edwards Lifesciences Corporation | 1.4 Billion USD | 93.536% |
| Paragon 28, Inc. | -47.84 Million USD | 289.482% |
| Glaukos Corporation | -134.66 Million USD | 167.317% |
| Globus Medical, Inc. | 122.87 Million USD | 26.225% |
| Inspire Medical Systems, Inc. | -21.15 Million USD | 528.544% |
| Medtronic plc | 3.67 Billion USD | 97.534% |
| Nevro Corp. | -92.21 Million USD | 198.305% |
| Owlet, Inc. | -32.9 Million USD | 375.524% |
| Penumbra, Inc. | 90.95 Million USD | 0.334% |
| Vicarious Surgical Inc. | -71.07 Million USD | 227.549% |
| Smith & Nephew plc | 263 Million USD | 65.532% |
| Sonendo, Inc. | -60.91 Million USD | 248.804% |
| STERIS plc | 378.23 Million USD | 76.034% |
| Stryker Corporation | 3.16 Billion USD | 97.136% |
| Vapotherm, Inc. | -58.19 Million USD | 255.775% |
| Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | 91.147% |